Finate 200mg Tablet
By Finate
Rx
10 Tablet in a Strip

Composition
Fenofibrate(200mg)

Manufacturer - Franco-Indian Pharmaceuticals Pvt Ltd
20, Dr. E. Moses Road, Mahalaxmi, Mumbai - 400 011

Expires on or after
March, 2027

liver
It is important to exercise caution when using Finate 200mg Tablet, especially if you have liver disease. Patients with liver issues should avoid using this medication as it may not be safe for them. It is advisable to consult your doctor before starting Finate 200mg Tablet to ensure it is suitable for you. Additionally, the use of this tablet is not recommended for individuals with severe liver disease. Always seek medical advice and guidance to make informed decisions regarding the use of Finate 200mg Tablet.

kidney
Finate 200mg Tablet requires caution in kidney disease. Dosage adjustment may be necessary. Consult your doctor. Avoid in severe kidney disease.

alcohol
Consult your doctor when consuming alcohol with Finate 200mg Tablet.

driving
Finate 200mg Tablet usually does not impact driving ability.

pregnancy
Finate 200mg Tablet may not be safe during pregnancy. Limited human studies suggest potential harm to the developing baby, as seen in animal studies. Your doctor will assess the benefits and risks before prescribing. It is important to consult your doctor.

breastfeeding
Finate 200mg Tablet should be avoided during breastfeeding as it is likely unsafe. Limited data indicates the drug may pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | PPAR alpha |
Therapeutic Class | - |
Action Class | PPAR alpha agonists (Fibrate) |
₹110
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024